Leap Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LPTX and other ETFs, options, and stocks.

About LPTX

Leap Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted and immuno-oncology therapeutics. Its novel therapies are designed to treat patients with cancer. 

CEO
Doug E. Onsi
CEODoug E. Onsi
Employees
52
Employees52
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2011
Founded2011
Employees
52
Employees52

LPTX Key Statistics

Market cap
16.45M
Market cap16.45M
Price-Earnings ratio
-0.23
Price-Earnings ratio-0.23
Dividend yield
Dividend yield
Average volume
412.01K
Average volume412.01K
High today
$0.4099
High today$0.4099
Low today
$0.39
Low today$0.39
Open price
$0.4099
Open price$0.4099
Volume
15.79K
Volume15.79K
52 Week high
$4.79
52 Week high$4.79
52 Week low
$0.2223
52 Week low$0.2223

People also own

Based on the portfolios of people who own LPTX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.